Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Deffond

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Presse Medicale (Paris, France : 1983)|May 13, 1989
[12th cranial nerve paralysis in high cervical carotid dissection]D Vernay, D Deffond, F Durif, et al.
Revue Neurologique|January 1, 1989
[Neurologic involvement in campylobacter infections. 5 cases]P Clavelou, J Beytout, A Gourdiat, et al.
Revue Neurologique|October 10, 2006
[Cognitive impairment and quality of life in multiple sclerosis patients]L Gerbaud, D Deffond, A Mulliez, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 22, 2001
Spontaneous internal carotid artery dissection with lower cranial nerve palsyN Guy, D Deffond, J Gabrillargues, et al.
Revue Neurologique|April 1, 1996
[Neurogenic muscle hypertrophy: 3 cases]D Deffond, P Clavelou, R Colamarino, et al.
Annales De Medecine Interne|January 1, 1995
[Pure sensory neuropathy, disclosing primary hyperparathyroidism]C Roche, D Deffond, J Schmidt, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Relation between plasma concentration and clinical efficacy after sublingual single dose apomorphine in Parkinson's diseaseF Durif, E Jeanneau, F Serre-Debeauvais, et al.
Therapie|September 1, 1994
[During the treatment or after... drug-induced convulsive accidents. Apropos of 70 cases]M Zenut-Leaud, D Deffond, E Cros, et al.
Clinical Neuropharmacology|April 1, 1993
Relation between clinical efficacy and pharmacokinetic parameters after sublingual apomorphine in Parkinson's diseaseF Durif, M Paire, D Deffond, et al.
Journal of Neural Transmission. Supplementum|January 1, 1995
Lack of pharmacokinetic interaction between the selective dopamine agonist cabergoline and the MAO-B inhibitor selegilineP Dostert, M Strolin Benedetti, S Persiani, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Presse Medicale (Paris, France : 1983)|May 13, 1989
[12th cranial nerve paralysis in high cervical carotid dissection]D Vernay, D Deffond, F Durif, et al.
Revue Neurologique|January 1, 1989
[Neurologic involvement in campylobacter infections. 5 cases]P Clavelou, J Beytout, A Gourdiat, et al.
Revue Neurologique|October 10, 2006
[Cognitive impairment and quality of life in multiple sclerosis patients]L Gerbaud, D Deffond, A Mulliez, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 22, 2001
Spontaneous internal carotid artery dissection with lower cranial nerve palsyN Guy, D Deffond, J Gabrillargues, et al.
Revue Neurologique|April 1, 1996
[Neurogenic muscle hypertrophy: 3 cases]D Deffond, P Clavelou, R Colamarino, et al.
Annales De Medecine Interne|January 1, 1995
[Pure sensory neuropathy, disclosing primary hyperparathyroidism]C Roche, D Deffond, J Schmidt, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Relation between plasma concentration and clinical efficacy after sublingual single dose apomorphine in Parkinson's diseaseF Durif, E Jeanneau, F Serre-Debeauvais, et al.
Therapie|September 1, 1994
[During the treatment or after... drug-induced convulsive accidents. Apropos of 70 cases]M Zenut-Leaud, D Deffond, E Cros, et al.
Clinical Neuropharmacology|April 1, 1993
Relation between clinical efficacy and pharmacokinetic parameters after sublingual apomorphine in Parkinson's diseaseF Durif, M Paire, D Deffond, et al.
Journal of Neural Transmission. Supplementum|January 1, 1995
Lack of pharmacokinetic interaction between the selective dopamine agonist cabergoline and the MAO-B inhibitor selegilineP Dostert, M Strolin Benedetti, S Persiani, et al.
Pageof 3